# An Exploratory Study of Golidocitinib in Adult Patients With ITP

> **NCT07196163** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Immune Thrombocytopenia (ITP)

## Interventions

- **DRUG:** Golidocitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07196163
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10-30
- **Primary completion:** 2028-10-30
- **Final completion:** 2029-10-30
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2025-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07196163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07196163, "An Exploratory Study of Golidocitinib in Adult Patients With ITP". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07196163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*